Prospective diagnosis of Covid-19 infection using exhaled breath analysis by electronic nose

Prospective diagnosis of Covid-19 infection using exhaled breath analysis by electronic nose - COVINOSE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54883

Enrollment

10300

Registered

2020-04-16

Start date

2020-04-17

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute respiratory tract infection flu

Interventions

None listed

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: acute respiratory tract infection, COVID-19 infection

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Recent (

Design outcomes

Primary

Measure	Time frame
Main study parameters/endpoints: Exhaled breath profiles obtained by sampling exhaled air using real time eNose technology to determine COVID-19 infection	—

Secondary

Measure	Time frame
To assess the accuracy of exhaled breath analysis by eNose at baseline for discrimination between individuals with different disease progression (e.g. mild respiratory symptoms, ICU admission and death).	—

Countries

Netherlands

Outcome results